JP2004536834A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004536834A5 JP2004536834A5 JP2003510077A JP2003510077A JP2004536834A5 JP 2004536834 A5 JP2004536834 A5 JP 2004536834A5 JP 2003510077 A JP2003510077 A JP 2003510077A JP 2003510077 A JP2003510077 A JP 2003510077A JP 2004536834 A5 JP2004536834 A5 JP 2004536834A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- growth hormone
- mammal
- composition according
- hypertension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000018997 Growth Hormone Human genes 0.000 claims 16
- 108010051696 Growth Hormone Proteins 0.000 claims 16
- 239000000122 growth hormone Substances 0.000 claims 16
- 239000008194 pharmaceutical composition Substances 0.000 claims 16
- 241000124008 Mammalia Species 0.000 claims 10
- 239000003446 ligand Substances 0.000 claims 6
- 206010020772 Hypertension Diseases 0.000 claims 5
- 230000003054 hormonal effect Effects 0.000 claims 5
- 230000017066 negative regulation of growth Effects 0.000 claims 5
- 239000000126 substance Substances 0.000 claims 5
- 208000007530 Essential hypertension Diseases 0.000 claims 4
- 208000024891 symptom Diseases 0.000 claims 3
- 239000002220 antihypertensive agent Substances 0.000 claims 2
- 229940030600 antihypertensive agent Drugs 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000001605 fetal effect Effects 0.000 claims 2
- 239000005541 ACE inhibitor Substances 0.000 claims 1
- 229940123413 Angiotensin II antagonist Drugs 0.000 claims 1
- 208000001362 Fetal Growth Retardation Diseases 0.000 claims 1
- 206010070531 Foetal growth restriction Diseases 0.000 claims 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 claims 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 230000003111 delayed effect Effects 0.000 claims 1
- 208000030941 fetal growth restriction Diseases 0.000 claims 1
- 230000012010 growth Effects 0.000 claims 1
- 239000007943 implant Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 210000004291 uterus Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ51283201 | 2001-07-06 | ||
| PCT/NZ2002/000118 WO2003004068A1 (en) | 2001-07-06 | 2002-07-04 | Hypertension treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004536834A JP2004536834A (ja) | 2004-12-09 |
| JP2004536834A5 true JP2004536834A5 (enExample) | 2006-01-05 |
Family
ID=19928540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003510077A Pending JP2004536834A (ja) | 2001-07-06 | 2002-07-04 | 高血圧症治療 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20040248788A1 (enExample) |
| EP (1) | EP1411924A1 (enExample) |
| JP (1) | JP2004536834A (enExample) |
| WO (1) | WO2003004068A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2118123E (pt) | 2007-01-31 | 2016-02-10 | Harvard College | Péptidos de p53 estabilizados e suas utilizações |
| JP5631201B2 (ja) | 2007-03-28 | 2014-11-26 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ステッチングされたポリペプチド |
| MX355543B (es) | 2010-08-13 | 2018-04-20 | Aileron Therapeutics Inc Star | Macrociclos peptidomiméticos. |
| TWI643868B (zh) | 2011-10-18 | 2018-12-11 | 艾利倫治療公司 | 擬肽巨環化合物 |
| SG11201404648PA (en) | 2012-02-15 | 2014-09-26 | Aileron Therapeutics Inc | Peptidomimetic macrocycles |
| EP2819688A4 (en) | 2012-02-15 | 2015-10-28 | Aileron Therapeutics Inc | PEPTIDOMIMETIC MACROCYCLES CROSS-LINKED WITH TRIAZOLE AND THIOETHER |
| KR20150082307A (ko) | 2012-11-01 | 2015-07-15 | 에일러론 테라퓨틱스 인코포레이티드 | 이치환 아미노산 및 이의 제조 및 사용 방법 |
| SG11201702223UA (en) | 2014-09-24 | 2017-04-27 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and uses thereof |
| KR20170129879A (ko) | 2015-03-20 | 2017-11-27 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티드모방 거대고리 및 이의 용도 |
| US20250195525A1 (en) * | 2023-12-15 | 2025-06-19 | Boehringer Ingelheim Vetmedica Gmbh | Angiotensin ii receptor antagonist for the prevention of systemic diseases in cats |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4959358A (en) * | 1983-06-06 | 1990-09-25 | Beth Israel Hospital Assn. | Drug administration |
| US4818531A (en) * | 1985-02-06 | 1989-04-04 | Eli Lilly And Company | Growth hormone and thyroid hormone |
| GB8504099D0 (en) * | 1985-02-18 | 1985-03-20 | Wellcome Found | Physiologically active substances |
| US5036045A (en) * | 1985-09-12 | 1991-07-30 | The University Of Virginia Alumni Patents Foundation | Method for increasing growth hormone secretion |
| US4857637A (en) * | 1986-05-07 | 1989-08-15 | Genentech, Inc. | Methods and compositions for immunologically modulating growth hormone receptor activity |
| US4792546A (en) * | 1986-12-05 | 1988-12-20 | American Cyanamid Company | Method for increasing weight gains and reducing deposition of fat in animals |
| US4997825A (en) * | 1986-12-22 | 1991-03-05 | Eli Lilly And Company | Synergistic treatment method |
| US4839344A (en) * | 1987-06-12 | 1989-06-13 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
| IL82885A (en) * | 1987-06-15 | 1991-07-18 | Migal Galilee Technology Cente | Method and composition containing a peptide hormone for stimulating growth in poultry |
| US5122367A (en) * | 1989-03-31 | 1992-06-16 | Massachusetts Institute Of Technology | Polyanhydride bioerodible controlled release implants for administration of stabilized growth hormone |
| CA2120626C (en) * | 1991-10-07 | 2009-10-06 | Douglas Wilmore | Method for enhancing gut absorption |
| SE9601397D0 (sv) * | 1996-04-12 | 1996-04-12 | Pharmacia Ab | Use of growth hormone |
| GB2324726A (en) * | 1997-05-01 | 1998-11-04 | Merck & Co Inc | Combination Therapy for the Treatment of Osteoporosis |
| US6306826B1 (en) * | 1997-06-04 | 2001-10-23 | The Regents Of The University Of California | Treatment of heart failure with growth hormone |
| CA2352316A1 (en) * | 1998-11-26 | 2000-06-02 | Auckland Uniservices Limited | Treatment of hypertension |
| JP2003534237A (ja) * | 1999-11-03 | 2003-11-18 | ノボ ノルディスク アクティーゼルスカブ | 食欲の抑制又は満腹の惹起のための成長ホルモン又は成長ホルモン分泌促進物質の使用 |
| EP1113007A1 (en) * | 1999-12-24 | 2001-07-04 | Pfizer Inc. | Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
-
2002
- 2002-07-04 US US10/482,854 patent/US20040248788A1/en not_active Abandoned
- 2002-07-04 WO PCT/NZ2002/000118 patent/WO2003004068A1/en not_active Ceased
- 2002-07-04 JP JP2003510077A patent/JP2004536834A/ja active Pending
- 2002-07-04 EP EP02760910A patent/EP1411924A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0741567B1 (en) | Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds | |
| US8075914B2 (en) | Method and formulation for treating resistance to antihypertensives and related conditions | |
| WO1999047158A3 (en) | Therapeutic chemokine receptor antagonists | |
| SK284923B6 (sk) | Zmes liečiv s antidepresívnym účinkom obsahujúca 2-amino-4,5,6,7- tetrahydro-6-propylaminobenzotiazol a sertralín a jej použitie | |
| JP2004536834A5 (enExample) | ||
| JP2005515214A5 (enExample) | ||
| SK138095A3 (en) | Transdermal therapeutic system for the administration of serotonin agonists | |
| WO2007084651A2 (en) | Methods and kits to treat chronic inflammatory immune diseases | |
| US6281222B1 (en) | Compositions and method for treatment of acetaminophen intoxication | |
| JP2002530353A5 (enExample) | ||
| ES2265910T3 (es) | Uso de antagonistas de receptores de angiotensina ii para el tratamiento de infarto agudo de miocardio. | |
| JPH01261334A (ja) | アンギオテンシン転換酵素阻害剤を有効成分とした医療用調剤及びその製造方法 | |
| MY143571A (en) | Eplerenone crystalline form | |
| KR100907583B1 (ko) | 굴심방 결절 Ｉｆ 전류 억제제와 앤지오텐신 전환 효소억제제의 회합체, 및 이를 함유한 약제 조성물 | |
| Fogari et al. | Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives | |
| HU212941B (en) | Process for producing synergetic, antihypertensive pharmaceutical compositions containing verapamil and trandolapril | |
| Lambova | Treatment of Raynaud s Phenomenon | |
| JPS6379831A (ja) | １，４−ジビドロピリジン誘導体およびアシル化１，２，３，４−テトラヒドロイソキノリン−３−カルボン酸を含有する医薬組成物 | |
| CN102274160B (zh) | 用于治疗对抗高血压药的抗药性和相关病症的方法和制剂 | |
| RU2498797C2 (ru) | Комбинированное средство для лечения гриппа и орви | |
| JP2004529893A5 (enExample) | ||
| JPS63130534A (ja) | 胃腸病の治療用組成物 | |
| HK1164136B (en) | Method and formulation for treating resistance to antihypertensives and related conditions | |
| Schaefer et al. | 14. Management of Adverse Drug Reactions | |
| Isenovic et al. | O-37: Effect of vasopeptidase inhibition BMS189921 on PI3-kinase signaling in VSMCs |